Robert Scammell, Author at Pharmaceutical Technology

04 Sep 2020

Tech

CTO Talk: Q&A with Forescout’s Robert McNutt

04 Sep 2020

27 Aug 2020

Tech

CTO Talk: Q&A with Healx’s Meri Williams

27 Aug 2020

26 Aug 2020

Tech

Huawei loses landmark patent case at Supreme Court

26 Aug 2020

31 Jul 2020

Tech

CTO Talk: Q&A with Exasol’s Mathias Golombek

31 Jul 2020

23 Jul 2020

Tech

CTO Talk: Q&A with HCL Technologies’ Kalyan Kumar

23 Jul 2020

16 Jul 2020

Tech

CTO Talk: Q&A with PragmatIC’s Richard Price

16 Jul 2020

14 Jul 2020

Tech

Huawei banned from UK 5G network from 2021

14 Jul 2020

10 Jul 2020

Tech

CTO Talk: Q&A with Scandit’s Christian Floerkemeier

10 Jul 2020

06 Jul 2020

Tech

Huawei’s days in the UK’s 5G network look numbered – here’s why

06 Jul 2020

02 Jul 2020

Tech

CTO Talk: Q&A with Acquia’s Dries Buytaert

02 Jul 2020

Sections

Most Read

Most Recent

Twist and Neogene partner to develop next-gen T cell therapies

Most Read

Most Recent

The relationship between FDI and international trade

Sections

Most Read

Most Recent

Breast Cancer Awareness Month – the importance of early diagnosis

Most Read

Most Recent

Aurobindo Pharma to sell US subsidiary to New Mountain Capital affiliate

Most Read

Most Recent

US election: where do the candidates stand on Covid-19 response?

Sections

Most Read

Most Recent

Castium

Robert Scammell

CTO Talk: Q&A with Forescout’s Robert McNutt

CTO Talk: Q&A with Healx’s Meri Williams

Huawei loses landmark patent case at Supreme Court

CTO Talk: Q&A with Exasol’s Mathias Golombek

CTO Talk: Q&A with HCL Technologies’ Kalyan Kumar

CTO Talk: Q&A with PragmatIC’s Richard Price

Huawei banned from UK 5G network from 2021

CTO Talk: Q&A with Scandit’s Christian Floerkemeier

Huawei’s days in the UK’s 5G network look numbered – here’s why

CTO Talk: Q&A with Acquia’s Dries Buytaert

Sections

Most Read

Most Recent

Most Read

Most Recent

Sections

Most Read

Most Recent

Most Read

Most Recent

Most Read

Most Recent

Sections

Most Read

Most Recent

Join Our Newsletter